Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5284092
Max Phase: Preclinical
Molecular Formula: C27H25N3O4
Molecular Weight: 455.51
Associated Items:
ID: ALA5284092
Max Phase: Preclinical
Molecular Formula: C27H25N3O4
Molecular Weight: 455.51
Associated Items:
Canonical SMILES: O=C1c2cc(N3CCOCC3)c(Cc3ccccc3)nc2C(c2ccco2)N1Cc1ccco1
Standard InChI: InChI=1S/C27H25N3O4/c31-27-21-17-23(29-10-14-32-15-11-29)22(16-19-6-2-1-3-7-19)28-25(21)26(24-9-5-13-34-24)30(27)18-20-8-4-12-33-20/h1-9,12-13,17,26H,10-11,14-16,18H2
Standard InChI Key: UDFJUGZZPADPPB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 455.51 | Molecular Weight (Monoisotopic): 455.1845 | AlogP: 4.44 | #Rotatable Bonds: 6 |
Polar Surface Area: 71.95 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.17 | CX Basic pKa: 2.30 | CX LogP: 3.52 | CX LogD: 3.52 |
Aromatic Rings: 4 | Heavy Atoms: 34 | QED Weighted: 0.43 | Np Likeness Score: -1.13 |
1. Morales-Salazar I, Montes-Enríquez FP, Garduño-Albino CE, García-Sánchez MA, Ibarra IA, Rojas-Aguirre Y, García-Hernández ME, Sarmiento-Silva RE, Alcaraz-Estrada SL, Díaz-Cervantes E, González-Zamora E, Islas-Jácome A.. (2023) Synthesis of bis-furyl-pyrrolo[3,4-b]pyridin-5-ones via Ugi-Zhu reaction and in vitro activity assays against human SARS-CoV-2 and in silico studies on its main proteins., 14 (1.0): [PMID:36760742] [10.1039/d2md00350c] |
Source(1):